Global X Fds genomic biotech shares owned by Manhattan West Asset Management
Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Manhattan West Asset Management
from 13F filings
Historical chart of Manhattan West Asset Management investment in Global X Fds genomic biotech
Tip: Access up to 7 years of quarterly data
All positions including Global X Fds genomic biotech held by Manhattan West Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Global X Fds genomic biotech by Manhattan West Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $344k | 31k | 11.25 |
| 2024-06-30 | $278k | 27k | 10.44 |
| 2024-03-31 | $309k | 27k | 11.38 |
| 2023-12-31 | $438k | 38k | 11.56 |
| 2023-09-30 | $1.1M | 121k | 9.16 |
| 2023-06-30 | $1.1M | 92k | 12.12 |
| 2023-03-31 | $793k | 64k | 12.32 |
| 2022-12-31 | $692k | 55k | 12.65 |
| 2022-09-30 | $697k | 56k | 12.55 |
| 2022-06-30 | $621k | 51k | 12.22 |
| 2022-03-31 | $610k | 41k | 15.04 |
More positions owned by Manhattan West Asset Management
View all positions for Manhattan West Asset Management